The process of angiogenesis plays a crucial role in the pathogenesis of numerous diseases, including but not limited to tumor growth/metastasis, diabetic retinopathy, and in tissue remodeling upon injury. Angiogenesis is driven by Vascular Endothelial Growth Factor (VEGF) and cell adhesion receptors, integrins on endothelial and blood cells. We have shown that one of the crucial regulatory events in angiogenesis is the cross-talk between VEGF receptor 2 and ?V?3 integrin. However, the pathological consequences and structural requirements for this crosstalk have yet to be determined. We have shown that a number of integrin-dependent functions are controlled by Akt pathway. However, due to the complexity of downstream targets, the exact role of Akt isoforms in the regulation of distinct cellular events of angiogenesis remains poorly understood. As our specific hypotheses, we propose that VEGFR2/?V?3 complex is crucial for the regulation of integrin-dependent functions and for the overall angiogenic response;and that Akt kinase pathway plays a central role in regulation of integrin activity and extracellular matrix composition during pathological angiogenesis. The following Specific Aims are proposed to test these hypotheses:
Aim 1. To determine the structural requirements and the biological role of the complex between ?3 integrin and VEGFR2 in vitro and in vivo. In order to demonstrate the key regulatory role of the complex, we will disrupt it using recently generated and characterized compounds. The role of the ?3/VEGFR2 complex will be assessed in angiogenesis-related assays in vitro. The role of the complex will be elucidated in vivo in implanted tumors, wounds and ischemic tissues. Special consideration will be given to the role of ?3 integrin and ?3/VEGFR2 complex in the regulation of bone marrow-derived cell recruitment to neovasculature. These studies will not only determine the basic mechanisms of angiogenesis, they will lead to the generation of a new anti-angiogenic strategy.
Aim 2. To further elucidate the mechanisms of integrin and extracellular matrix regulation by Akt pathway. A) Using Akt-1 and Akt-2 null mice recently characterized by our lab, we will further elucidate the role of Akt signaling in the regulation of integrin activity. The role of Akt1/2 signaling in the regulation of integrin-dependent extracellular matrix expression and assembly will be determined. Since Akt1 influenced functions of numerous cell types involved in angiogenesis, we will define the role of endothelial Akt1 in angiogenesis. A detailed understanding of how successful collaboration occurs between an initiator of angiogenesis, VEGF, an effector system, the integrins, will create the basis for the development of novel therapeutic strategies in cardiology, vascular medicine and cancer treatment.

Public Health Relevance

The major mechanism to adapt to regional ischemia resulting from myocardial infraction or peripheral vascular diseases is the development of new blood vessels, a process known as angiogenesis. In cancer, inhibition of angiogenesis suppresses tumor growth. Angiogenesis is triggered by Vascular Endothelial Growth Factor and dependent on the functions of integrins receptors. In order to be able to build functional blood vessels or inhibit their formation, a detailed knowledge of the mechanisms of angiogenesis is required. The goal of this proposal is to assess the molecular and cellular mechanisms of angiogenesis with an emphasis on pathophysiologically relevant models.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL071625-09
Application #
8206740
Study Section
Special Emphasis Panel (ZRG1-CVS-D (02))
Program Officer
Kindzelski, Andrei L
Project Start
2002-12-01
Project End
2013-12-31
Budget Start
2012-01-01
Budget End
2013-12-31
Support Year
9
Fiscal Year
2012
Total Cost
$388,575
Indirect Cost
$141,075
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Kim, Young-Woong; Byzova, Tatiana V (2014) Oxidative stress in angiogenesis and vascular disease. Blood 123:625-31
Ma, Lining; Kerr, Bethany A; Naga Prasad, Sathyamangla V et al. (2014) Differential effects of Akt1 signaling on short- versus long-term consequences of myocardial infarction and reperfusion injury. Lab Invest 94:1083-91
Panigrahi, Soumya; Ma, Yi; Hong, Li et al. (2013) Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. Circ Res 112:103-12
Malinin, Nikolay L; Pluskota, Elzbieta; Byzova, Tatiana V (2012) Integrin signaling in vascular function. Curr Opin Hematol 19:206-11
Goc, Anna; Choudhary, Mrunal; Byzova, Tatiana V et al. (2011) TGFýý- and bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR). J Cell Physiol 226:3004-13
Feng, Weiyi; Madajka, Maria; Kerr, Bethany A et al. (2011) A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing. Blood 117:3893-902
Somanath, Payaningal R; Podrez, Eugene A; Chen, Juhua et al. (2011) Deficiency in core circadian protein Bmal1 is associated with a prothrombotic and vascular phenotype. J Cell Physiol 226:132-40
West, Xiaoxia Z; Malinin, Nikolay L; Merkulova, Alona A et al. (2010) Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467:972-6
Malinin, Nikolay L; Zhang, Li; Choi, Jeongsuk et al. (2009) A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med 15:313-8
Somanath, P R; Vijai, J; Kichina, J V et al. (2009) The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt. Oncogene 28:2365-9

Showing the most recent 10 out of 30 publications